Clinical Trial Update: A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating hepatitis C infection in adult transplant recipients has completed, and results have been posted by AbbVie.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• AbbVie investigational regimen

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C Infection | Phase 2 | Status: COMPLETED | Results posted: 2017-11-07